Oscar Health

OSCR

Market cap $4.06B

Zacks.com users have recently been watching Oscar Health (OSCR) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Oscar Health (OSCR) stock has declined by 21.7% in under a month, from $15.70 on January 26, 2026, to $12.30 currently. Should you consider purchasing this dip?

Health insurance stocks have been beaten down over the last year. Oscar Health is a disruptive health insurer set for a profit rebound this year.

Oscar Health (OSCR) leverages technology to drive operational efficiency and profitability in a challenging health insurance environment. Despite industry headwinds, OSCR's individual member retention remains strong, supporting optimism for revenue growth and market share gains. 2026 guidance targets $18.7–$19.0B revenue, 82.4–83.4% MLR, 15.8–16.3% SG&A, and $250–$450M operating earnings, implying significant valuation upside.

Oscar Health, Inc. reported 27% YoY revenue growth to $11.7bn in 2025 but remained unprofitable, missing analyst EPS and revenue estimates in Q4. OSCR expects >60% revenue growth in 2026 to $18.85bn at midpoint guidance, a return to profitability, and significant operating earnings improvement. Membership is projected to grow ~58% YoY to ~3 million, with AI-driven cost reductions and targeted product offerings supporting margin expansion.

In this video, I will cover Oscar Health's (OSCR +1.74%) recent earnings report and call. Watch the short video to learn more, consider subscribing, and click the special offer link below.

The healthcare company published its latest set of financial figures. It missed analyst estimates on both the top and bottom lines, but this was overshadowed by very bullish revenue guidance.

Oscar Health Inc. (NYSE: OSCR) on Tuesday reported fourth-quarter revenue of approximately $2.81 billion, compared to $2.39 billion a year ago, missing the consensus estimate of $3.12 billion.

Oscar Health, Inc. (OSCR) Q4 2025 Earnings Call Transcript

Although the revenue and EPS for Oscar Health (OSCR) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.